January 29, 2018 Chromatography Lab Top-10 Product Launch

Waters BioResolve RP mAb Polyphenyl Columns, Setting a New Standard for Reversed-Phase Separations of Monoclonal Antibodies and Antibody Drug Conjugates

Waters’ new BioResolve RP mAb Polyphenyl Columns are for the analysis of intact or sub-unit-digested monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) by reversed phase liquid chromatography (LC) and LC-mass spectrometry. (Photo: Business Wire) January 29, 2018 01:00 PM Eastern Standard Time MILFORD, Mass.–(BUSINESS WIRE)–Waters Corporation (NYSE:WAT) today introduced BioResolve™ RP mAb Polyphenyl 450 angstrom 2.7... Read more

January 24, 2018 Chromatography Lab Top-10 Product Launch

Waters New Oasis PRiME MCX Cartridges and Plates Remove Phospholipids and Other Interferences from Biological Matrices

New Sample Preparation Workflow Produces Exceptionally Clean Samples for Robust and Accurate LC and LC-MS Quantification Waters New Oasis PRiME MCX Cartridges and Plates Remove Phospholipids and Other Interferences from Biological Matrices (Photo: Business Wire). January 24, 2018 08:30 AM Eastern Standard Time MILFORD, Mass.–(BUSINESS WIRE)–Waters Corporation (NYSE:WAT) today introduced Waters® Oasis® PRiME MCX Cartridges and 96-Well Plates which... Read more

January 16, 2018 Chromatography Lab Top-10 M&A, Partnerships

Waters and Malvern Panalytical Collaborate to Improve Polymer Characterization

Coupling of technologies delivers advanced information with superior speed and resolution compared to traditional Gel Permeation Chromatography (GPC) MILFORD, Mass.–(BUSINESS WIRE)–Jan. 16, 2018– Waters Corporation (NYSE:WAT) announced that it entered into a co-marketing agreement with Malvern Panalytical to advance the analysis of polymers. By pairing the Waters®ACQUITY® Advanced Polymer Chromatography® (APC™) System with Malvern Panalytical’s OMNISEC® REVEAL, R&D scientists can access higher sensitivity,... Read more

October 19, 2017 Lab Top-10 PR/Corporate

Doug Berthiaume to Retire as Chairman of the Board of Waters Corporation; Chris O’Connell Elected as New Chairman

October 19, 2017 04:15 PM Eastern Daylight Time MILFORD, Mass.–(BUSINESS WIRE)–Waters Corporation (NYSE: WAT) announced today that Douglas A. Berthiaume will retire as Chairman of the Board of Directors of the Company, effective December 31, 2017. The Board of Directors has elected Christopher J. O’Connell, President and Chief Executive Officer, as its new Chairman effective... Read more

June 22, 2017 Lab Top-10 PR/Corporate

Waters Corporation Elects Flemming Ornskov to Board of Directors

June 22, 2017 04:30 AM Pacific Daylight Time MILFORD, Mass.–(BUSINESS WIRE)–Waters Corporation (NYSE: WAT) today announced Dr. Flemming Ornskov, Chief Executive Officer of Shire plc, has been elected as a Director of Waters® Corporation effective today. “It is an honor to welcome Flemming Ornskov to our Board of Directors,” said Christopher J. O’Connell, Waters Corporation President... Read more

June 8, 2017 Chromatography Lab Top-10 Liq. Handling & Robotics M&A, Partnerships Mass Spectrometry

Waters and Andrews Alliance Sign Co-Marketing Agreement: Firms to Co-Market New Semi-Automated Sample Preparation Approach for Protein Therapeutics Glycosylation Profiling

Waters Corporation (NYSE:WAT) and Andrew Alliance today announced they have signed an agreement that will bring drug development scientists an easy-to-use, semi-automated sample preparation approach for released N-glycan profiling and analysis by LC and LC-MS. Under the co-marketing agreement, Waters will combine its existing Glycoworks™ RapiFluor-MS™ (RFMS) N-Glycan Kits with an Andrew pipetting robot that... Read more

June 8, 2017 Chromatography Lab Top-10 Mass Spectrometry

Waters UPLC and Mass Spectrometry Systems Approved for In-Vitro Diagnostic use in Brazil

Clinical laboratories now have access to enhanced levels of selectivity, sensitivity, and versatility from Waters’ newest UPLC-MS/MS technologies MILFORD, Mass.–(BUSINESS WIRE)–Jun. 8, 2017– Waters Corporation (NYSE: WAT) today announced that Brazil’sNational Health Surveillance Agency (ANVISA) has approved the Waters® ACQUITY® UPLC®, ACQUITY UPLC® I-Class System, and three mass spectrometers, the Xevo® TQD, Xevo TQ-S micro,... Read more

May 31, 2017 Chromatography Lab Top-10 M&A, Partnerships Molecular Spectroscopy

Waters and Wyatt Collaborate to Advance Polymer Analysis and Biopharmaceutical Characterization Studies

Coupling of technologies delivers valuable information 5x faster than conventional size exclusion chromatography (SEC) MILFORD, Mass.–(BUSINESS WIRE)–May 31, 2017– Waters Corporation (NYSE:WAT) announced that it entered into a Co-Marketing agreement with Wyatt Technology to advance the analysis of synthetic polymers and biotherapeutic proteins. By pairing Waters® ACQUITY® UPLC® and Waters® ACQUITY® Advanced Polymer Chromatography® (APC™)... Read more

April 19, 2017 Environ, Ag./Food & Bev Lab Top-10 Product Launch

VICAM Introduces New Rapid, Solvent-free Method for Ochratoxin A Detection in Coffee and Wheat

The Ochra-V AQUA eliminates the use of organic solvents while also significantly reducing testing time MILFORD, Mass.–(BUSINESS WIRE)–Apr. 19, 2017– Waters Corporation (NYSE:WAT) announced VICAM®, a Waters® Business, now offers a rapid, eco-friendly lateral flow strip test specifically for the detection of ochratoxin A in green coffee and wheat. Compared to traditional methods, the Ochra-V®... Read more

March 13, 2017 Lab Top-10 PR/Corporate

RedShift BioAnalytics, Inc. Completes $11.0 million Series C Financing

Financing to Drive Commercialization of Next Generation Biotechnology Instrumentation for Drug Discovery and Development BURLINGTON, MA – March 13, 2017 – RedShift BioAnalytics, Inc., an innovative provider of bioanalytical instrumentation for the research, development and manufacturing of protein therapeutic drugs, today announced the closing of the Company’s $11.0 million Series C Preferred Stock financing. The... Read more